| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2ccd31c6fb4a48d57cfdad96c738aa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-544
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 |
| filingDate |
2004-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc1a97855b1edfb7cb7c27655ebae28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_319031ef7d240ff93c29b94920fce75b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd30655206b12d868ecb396474f453d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab96b24431e2ee16a00e6041390e4087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7173935f65c522a15e19e99a3a16cf8 |
| publicationDate |
2007-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
OA-13272-A |
| titleOfInvention |
Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes. |
| abstract |
The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano: phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical fomrulations of the Apo A-I Milano: phospholipid complexes are also provided. |
| priorityDate |
2003-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |